Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by HW de Valk
Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy vs Continuous Subcutaneous Insulin Infusion in Patients With Type 1 Diabetes in the Netherlands
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Related publications
Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes
JAMA - Journal of the American Medical Association
Medicine
Consequences of Delayed Pump Infusion Line Change in Patients With Type 1 Diabetes Mellitus Treated With Continuous Subcutaneous Insulin Infusion
Journal of Diabetes and its Complications
Internal Medicine
Endocrinology
Metabolism
Diabetes
Preconceptional Diabetes Control in Insulin-Dependent Diabetes Mellitus Patients With Continuous Subcutaneous Insulin Infusion Therapy
Journal of Perinatal Medicine
Gynecology
Child Health
Pediatrics
Perinatology
Obstetrics
Clinical and Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion for Diabetes
Health Technology Assessment
Medicine
Health Policy
Blinded Continuous Glucose Monitoring During Yom Kippur Fasting in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Once-Weekly Exenatide as Adjunct Treatment of Type 1 Diabetes Mellitus in Patients Receiving Continuous Subcutaneous Insulin Infusion Therapy
Canadian Journal of Diabetes
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Vitiligo Associated With Subcutaneous Insulin Lispro Infusion in Type 1 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Continuous Subcutaneous Insulin Infusion
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Cost-Effectiveness of Continuous Glucose Monitoring and Intensive Insulin Therapy for Type 1 Diabetes
Cost Effectiveness and Resource Allocation
Health Policy